Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 125.09M P/E 19.16 EPS this Y 16.30% Ern Qtrly Grth -
Income -16.78M Forward P/E 66.18 EPS next Y 158.50% 50D Avg Chg -6.00%
Sales 44.38M PEG - EPS past 5Y 389.90% 200D Avg Chg -16.00%
Dividend N/A Price/Book 2.05 EPS next 5Y - 52W High Chg -45.00%
Recommedations 2.00 Quick Ratio 1.97 Shares Outstanding 19.08M 52W Low Chg 10.00%
Insider Own 22.06% ROA -15.05% Shares Float 14.05M Beta -0.27
Inst Own 9.51% ROE -29.70% Shares Shorted/Prior 274.69K/248.19K Price 7.28
Gross Margin 36.59% Profit Margin -37.81% Avg. Volume 66,377 Target Price 21.00
Oper. Margin -324.44% Earnings Date May 9 Volume 19,951 Change -2.67%
About ProPhase Labs, Inc.

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

ProPhase Labs, Inc. News
05/02/24 ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
05/02/24 PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
04/29/24 Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
04/25/24 ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
04/23/24 Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
04/16/24 ProPhase Labs Unveils Project ZenQ-AI
04/15/24 Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
04/10/24 ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
04/01/24 ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/18/24 ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript
03/15/24 ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
03/08/24 PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
03/01/24 ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 29% Above Their Intrinsic Value Estimate
02/20/24 ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART
02/14/24 ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
02/08/24 Diamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI)
01/30/24 ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
01/23/24 Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
08:00 AM ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
11/10/23 ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript
PRPH Chatroom

User Image Stock_Titan Posted - 1 day ago

$PRPH PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9 https://www.stocktitan.net/news/PRPH/prophase-labs-inc-to-present-first-quarter-2024-financial-results-on-skj9wmk9apr9.html

User Image Stock_Titan Posted - 04/25/24

$PRPH ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 https://www.stocktitan.net/news/PRPH/pro-phase-labs-to-present-at-the-planet-micro-cap-showcase-vegas-wdwr63axfxkp.html

User Image DonCorleone77 Posted - 04/23/24

$PRPH Link below to a GlobalNewswire article entitled: "Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)" Here is the paragraoh on 'Valuation': We reiterate our valuation of ProPhase Labs, which has been actively pursuing growth through strategic expansions and innovative product introductions across its subsidiaries. Our updated valuation model incorporates the latest financial outcomes and refined estimates reflecting newly disclosed segment information. Furthermore, we have revisited our SOTP (Sum of the Parts) methodology, resulting in an adjusted valuation to $21.00 per share, up from the previous $20.00, contingent on the company's successful execution. https://finance.yahoo.com/news/diamond-equity-research-releases-note-130000492.html

User Image DonCorleone77 Posted - 04/22/24

$PRPH I was told at the moment that the ticker PRPH stands for "Preparation H." Let's see if that changes soon :o) :o) :o)

User Image johannn Posted - 04/20/24

$PRPH This could well be the reason why so many pumpers suddenly appeared on the prophase forum. https://www.sec.gov/ix?doc=/Archives/edgar/data/868278/000149315224015121/form8-k.htm

User Image SHill1103 Posted - 04/18/24

$PRPH bears effed lmao

User Image Maverick11 Posted - 04/18/24

$PRPH Grabbed a few K additional shares at $5.37. See a quick snap back to $7. AI news is totally transformative for the company. See double digits next couple of months. Will continue to add until core position along w/ $VKTX $SRUUF $MSTR $ALCC. Good luck all - Mav

User Image SHill1103 Posted - 04/18/24

$PRPH nice consolidation before we takeoff

User Image SHill1103 Posted - 04/18/24

$PRPH let’s go baby

User Image Finanz Posted - 04/18/24

$PRPH Hope most here too those profits off the table.

User Image SHill1103 Posted - 04/18/24

$PRPH $8

User Image _www_larval_com_ Posted - 04/18/24

$PRPH has stumbled -3% lower to -13% (~1Mv) a few minutes ago, 04/19 options, follow for more volatility.

User Image MCM5169 Posted - 04/18/24

$PRPH nice commercial pumpty Dumpty.

User Image TICKERTUTOR Posted - 04/17/24

$PRPH i think it can take out 10 on these AI tailwinds

User Image melissascrookedtooth Posted - 04/17/24

$PRPH new buyer. really like the financials, like growth story here

User Image RallyRaider Posted - 04/17/24

$PRPH pretty chart

User Image RallyRaider Posted - 04/17/24

$PRPH many press releases... company wants to get the story out there

User Image Maverick11 Posted - 04/17/24

$VKTX VKTX, $MSTR $ALCC $PRPH all on focus today. $VKTX represents hands down the single best opportunity in market from a r/r perspective. Downside is possibly a few points lower - upside is 3-4x. Prior to close each day I contemplate selling off some and redeploying capital for a short term trade elsewhere - can’t do it. . . At any minute literally deal can be announced and as days elapse that likelihood increases… good luck all. Mav

User Image Finanz Posted - 04/16/24

$PRPH

User Image DG20 Posted - 04/16/24

$ALCC $PRPH $VKTX If GATC Health ever goes public buy it hand over fist…

User Image Maverick11 Posted - 04/16/24

$VKTX Fellow longs - this feels ready to make a run. Fully loaded. Separately, recommended $PRPH 2 weeks ago here - https://stocktwits.com/Maverick11/message/567277502 - made its move today. (much) More to come. $ALCC ready to resume its move. Sam Altman backed co - he knows full that AI NEEDS new/innovative power generation - prop nuclear fission technology. Keep an eye. Good luck all. Mav

User Image Bigeyes2 Posted - 04/16/24

$PRPH swing-long

User Image TICKERTUTOR Posted - 04/16/24

$PRPH "Shares of ProPhase Labs jumped after the biopharma and diagnostics company unveiled a new project that utilizes an artificial-intelligence platform and its massive genomics database." ProPhase on Tuesday morning announced the launch of Project ZenQ-AI, which uses a state-of-the-art AI platform and its whole genomic sequencing tests to identify possible antibody drug conjugate for new cancer therapeutics. "This unique combination of sophisticated AI and rich, diverse genomic and proteomic data sources enhances our approach to cancer treatment as both innovative and effective," Chief Executive Ted Karkus said.

User Image CrayP Posted - 04/16/24

$PRPH Parkyourkarkas must be desperate... now putting out AI releases about businesses he knows nothing about when he still can't collect the receivables from past recognized receivables. He's got $5M of cash left and 300 days of receivables he's trying to collect on cause he didn't know what he was doing. Should have stuck to making lozenges....

User Image TICKERTUTOR Posted - 04/16/24

$PRPH got me...

User Image DonCorleone77 Posted - 04/16/24

$PRPH ProPhase Labs unveils Project ZenQ-AI ProPhase Labs announced an innovative step forward in cancer treatment research with the introduction of Project ZenQ-AI. This project employs the Company's state-of-the-art AI platform which was meticulously developed with leading AI technology platforms and systems. The Company is harnessing its extensive genomic database-built over the last six years from whole genome sequencing tests spanning more than 130 countries, and equivalent to roughly 150 million ancestry SNP-based tests. Whole Genome Sequencing offers an exhaustive exploration of an individual's entire DNA, capturing all three billion base pairs for a complete and detailed genetic blueprint. This comprehensive approach contrasts sharply with SNP tests, which target specific genetic variations at known locations, typically analyzing between 100,000 to 1 million specific points. With WGS providing up to 30,000 times more genetic data than SNP testing, our service delivers unparalleled precision in personalized medicine and genetic research, far beyond the scope of standard SNP testing. Along with the data gathered from the Company's BE-Smart Test for esophageal adenocarcinoma, the platform is being utilized to create algorithms that identify possible antibody drug conjugate candidates for new cancer therapeutics. Antibody drug conjugates are specialized treatments that differ from traditional chemotherapy by specifically targeting cancer cells. ADCs use a linker to attach chemotherapy agents to a monoclonal antibody, which then binds to a unique marker found on the surface of cancer cells. This targeted approach helps to minimize damage to healthy cells and other side effects. ADCs represent a potent class of cancer therapies, blending the specificity of monoclonal antibodies with cytotoxic drugs. Leveraging ZenQ-AI with both genomic and proteomic data is believed to enable the rapid identification of biomarkers and mutations driving cancer, streamlining the design of ADCs for precise targeting. This integration promises more effective and personalized treatments, though rigorous experimental validation remains crucial for ensuring safety and efficacy of new therapeutic candidates. "The power of Project ZenQ-AI not only stems from cutting-edge AI technology, but also the vast and growing genomic database that we've curated and continue to grow," explained Ted Karkus, CEO at ProPhase Labs. "This unique combination of sophisticated AI and rich, diverse genomic and proteomic data sources enhances our approach to cancer treatment as both innovative and effective."

User Image Stock_Titan Posted - 04/16/24

$PRPH ProPhase Labs Unveils Project ZenQ-AI https://www.stocktitan.net/news/PRPH/pro-phase-labs-unveils-project-zen-q-am3um2qqr5td.html

User Image DonCorleone77 Posted - 04/11/24

@MaverikIT @net0trader @Wigglyick @Cash4freedom @RonIsWrong @Im_not_Mr_Lebowski @IsabellaDC I am attributing today's move higher in $PRPH 100% to the fact that I took a starter position yesterday :o) :o) :o)

User Image GuruChartist Posted - 04/11/24

$PRPH

Analyst Ratings
HC Wainwright & Co. Buy Feb 21, 24
HC Wainwright & Co. Buy Nov 10, 23
HC Wainwright & Co. Buy Aug 14, 23
HC Wainwright & Co. Buy Jun 2, 23
HC Wainwright & Co. Buy May 12, 23
HC Wainwright & Co. Buy Mar 8, 23
HC Wainwright & Co. Buy Feb 23, 23
HC Wainwright & Co. Buy Feb 16, 23
HC Wainwright & Co. Buy Feb 7, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Karkus Ted William CEO & CHAIRMAN CEO & CHAIRMAN Oct 16 Option 0.6 600,000 360,000 3,388,609 10/18/22
Karkus Ted William CEO & CHAIRMAN CEO & CHAIRMAN Aug 10 Option 0.6 600,000 360,000 3,105,214 08/10/22
Karkus Ted William CEO & CHAIRMAN CEO & CHAIRMAN May 23 Option 2 450,000 900,000 2,783,471 05/25/22
Brady Monica L. Chief Accounting Off.. Chief Accounting Officer May 23 Option 2.67 39,250 104,798 46,678 05/25/22
Barr Jason Michael Director Director Mar 10 Buy 6.48 721 4,672 30,962 04/11/22